I don't know the details of what is allowed or not. I would assume they can inspect the sites from time to time, but they shouldn't have any access to data and the sites would receive blinded materials for the patients and not know what patients are getting what treatment. That is the whole idea of a blinded trial, nobody along the chain should know anything.
Market Data 
Markets 
AI
